Corvus Pharmaceuticals, Inc. (CRVS) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: CRVS) | Delayed: 10.03 -0.2 (1.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.23 | 52 Week High | $17.77 | |||
| Open | $10.09 | 52 Week Low | $9.63 | |||
| Day High | $10.37 | P/E | N/A | |||
| Day Low | $9.78 | EPS | $0.00 | |||
| Volume | 845,085 | |||||
